tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 3 analysts with an average price target of $14.58. This is a potential upside of $12.77 (705.52%) from yesterday's end of day stock price of $1.81.
I-Mab's activity chart (see below) currently has 16 price targets and 25 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 31.25% with an average time for these price targets to be met of 77.25 days.
Highest price target for IMAB is $8, Lowest price target is $6, average price target is $14.58.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 12-Apr-2024. First documented stock forecast 27-Jul-2020.
Currently out of the existing stock ratings of IMAB, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$4.19 (231.49%)
8
13 days ago
0/5 (0%)
$4.19 (231.49%)
Buy
8
$6.19 (341.99%)
1 months 7 days ago
1/4 (25%)
$6.19 (341.99%)
85
Buy
7 months 20 days ago
3/4 (75%)
$13.97 (18.37%)
133
Buy
35
1 years 22 days ago
1/4 (25%)
$26.73 (323.22%)
91
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?
